
Sumaya Jaludi, PharmD, instructor for pharmacy technology at Carrington College, discusses the importance of pharmacy technicians for National Pharmacy Technician Day, especially during the COVID-19 pandemic.

Sumaya Jaludi, PharmD, instructor for pharmacy technology at Carrington College, discusses the importance of pharmacy technicians for National Pharmacy Technician Day, especially during the COVID-19 pandemic.

Ismail Lourido Ali, the director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses what MAPS is, and how MAPS is engaged with the field of psychedelic medicine and its use in health care.

Meredith Ayers, CPhT, pharmacy technician at Bremo Pharmacy and presenter at the annual NCPA Convention 2021, discusses the expanding role of pharmacy technicians.

Survey results from COVID-19 Vaccine Education and Equity Project shows desire to protect kids from getting the coronavirus.

Pharmacy Tech Talk is designed to focus on the growing role and responsibilities for pharmacy technicians, the tools and trainings they need, and challenges they face.

“A great pharmacy technician makes all the difference in the success of our pharmacy.”

Dextromethorphan works on the part of the brain responsible for the cough reflex.

Ibrexafungerp is a triterpenoid antifungal drug for adult and post-menarchal pediatric females with vulvovaginal candidiasis.

As inflammation worsens, appendicitis pain typically increases and eventually becomes severe.

Technicians are recognized for playing a vital part in pharmacies, helping both patients and pharmacists.

Officials with the FDA have approved Zimhi 5 mg/0.5 mL, a high-dose naloxone injection product, for use in the treatment of opioid overdose.

Study results show that individuals who were vaccinated against the flu were 37% less likely to be hospitalized and 82% less likely to be admitted to the ICU that those who were unvaccinated.

Northwestern Medicine study results show that mice were protected from other strains when those from prior infections or in their vaccinations were greater than 70%.

As the first nasal spray for dry eye disease, varenicline solution nasal spray could be especially helpful for patients who have difficulty administering eye drops.

The approval marks the first and only cell-based influenza vaccine approved in the United States.


Eighteen states have enacted legislation that allows pharmacists to help patients when providers are not reachable.

The COVID-19 pandemic and the rapid digital adoption of mobile devices have changed the role of the community pharmacist.

Regular dialysis or kidney transplants are common treatment options that were disrupted after the beginning of COVID-19.

Misconceptions about the diagnosis of attention-deficit hyperactivity disorder reduce the credibility of health care providers and delay or prevent treatment for patients suffering from this condition.

Zinc can be used for colds, wound healing, diarrhea, and age-related macular degeneration.

The efficacy of Latuda in schizophrenia and bipolar depression could be mediated through a combination of central dopamine D2 and serotonin type 2 receptor antagonism.

Causes of aortic valve stenosis include congenital heart defect, calcium build-up on the valve, and rheumatic fever.

Pezzino discussed new specific prescriptions and treatments compared to current treatment modalities, indications and routes of administration of new drugs in the community setting, and important pharmacokinetic properties of these new drugs.

The Next-Generation Pharmacist Awards national program salutes pharmacy professionals who are defining the industry’s future.

Court evaluates whether allegations based on the Americans With Disabilities Act are sufficient for lawsuit to proceed

A booster shot of the Johnson & Johnson single-shot vaccine administered 56 days after the initial shot provided 94% protection against COVID-19.

The vaccine is used to prevent cervical cancer and other cancers, such as vulvar, vaginal, and oropharyngeal.

Temelimab is a recombinant humanized IgG4 monoclonal antibody that blocks the HERV-W protein, which is associated with the pathology of autoimmune disorders, such as multiple sclerosis and type 1 diabetes.

Although the advisory committee’s recommendation is not binding, the FDA will take their recommendation into consideration when making a final decision on authorization of the 50-µg booster dose.